SUBSTITUTED 3-FLUOROBENZENEPROPANOATE COMPOUND AND PREPARATION METHOD THEREFOR, PHARMACEUTICAL COMPOSITION THEREOF, AND USE THEREOF

SALT CRYSTALS

2-HYDROXY-5-[2-(4-(TRIFLUOROMETHYLPHENYL)ETHYLAMINO)]BENZOIC ACID CRYSTAL FORMS AND PREPARATION METHOD THEREFOR

ESTER COMPOUND

EBNA1 inhibitors and their method of use

SMALL MOLECULE INHIBITORS OF THE MCL-1 ONCOPROTEIN AND USES THEROF

Compounds for treatment of cardiac arrhythmias and heart failure

EBNA1 inhibitors and their method of use

Aromatic acetylene or aromatic ethylene compound, intermediate, preparation method, pharmaceutical composition and use thereof

COMPOUNDS, COMPOSITIONS, AND METHODS OF MAKING AND USING THE SAME

Small molecule inhibitors of the MCL-1 oncoprotein and uses thereof

Compounds and methods of treating ocular disorders

EBNA1 inhibitors and their method of use

Insecticidal compounds

INHIBITORS OF THE WNT SIGNALLING PATHWAYS

COMPOUNDS FOR TREATMENT OF CARDIAC ARRHYTHMIAS

Small molecule inhibitors of Mcl-1 and uses thereof

EBNA1 inhibitors and their method of use

Compounds

Insecticidal compounds

Substituted 2,2′-biphenazines for treating diseases

Anthranilic acid derivatives: novel inhibitors of advanced glycation end-products (AGEs) formation

Small molecules that covalently modify transthyretin

COMPOUNDS AND METHODS OF TREATING OCULAR DISORDERS

Aryl compounds for application in a highly polar solvent

Prodrug of an anti-inflammatory active ingredient

Carboxylic acid ester prodrug inhibitors of MEK

Derivatives of tetracaine

3-acyl-ingenols II

STABLE SYNTHETIC INTERMEDIATE AND METHOD FOR MANUFACTURING SAME

Preparation of 5-aminosalicylic acid by gas phase catalytic carboxylation

METHOD FOR PRODUCING CRYSTALLINE 5-AMINOSALICYLIC ACID

Derivatives of mesalazine, process of their preparation and their use in the treatment of intestinal inflammatory diseases

Photocrosslinkable materials

METHOD FOR PREPARING CHEMICAL COMPOUNDS OF INTEREST BY NUCLEOPHILIC AROMATIC SUBSTITUTION OF AROMATIC CARBOXYLIC ACID DERIVATIVES SUPPORTING AT LEAST ONE ELECTRO-ATTRACTIVE GROUP

Compounds and their salts specific to the PPAR receptors and the EGF Receptors and their use in the medical field

Compounds and methods of treating ocular disorders

Small molecules that covalently modify transthyretin

2,2′-biphenazine compounds and methods useful for treating disease

Sustainable chemical process for reduction of nitro compounds (R-NO2) or nitroso compounds (R-NO) containing sulphonic or carboxylic group into corresponding amino compounds (R-NH2) with inherent recycle of all acidic streams generated in synthesis

Lignin Oxidation and Products Thereof

Photocrosslinkable materials

1H-quinazoline-2,4-diones processes for their production, pharmaceutical compositions, and treatment for epilepsy

SALICYLIC ACID DERIVATIVES BEING FARNESYL PYROPHOSPHATE SYNTHASE ACTIVITY INHIBITORS

Preparation methods of 6 substituted amino-3 cyanoquinoline compounds and the intermediates thereof

Water soluble polyimide resin, its preparation and use

Process for producing 6-aryloxyquinoline derivative and intermediate therefor

BIS-ARYL COMPOUNDS FOR USE AS MEDICAMENTS

BIS-ARYL COMPOUNDS FOR USE AS MEDICAMENTS

Pyruvate Derivatives with Neuroprotective Effect, Process for Preparing the Same and Pharmaceutical Composition Comprising the Same

Manufacturing method of 2-hydroxy-5-phenylalkylaminobenzoic acid derivatives and their salts

Compounds, compositions and methods for preventing neurodegeneration in acute and chronic injuries in the central nervous system

Method for reducing neuronal death in nervous system injuries resulting from amyotrophic lateral sclerosis

N-(2,4-dioxo-6-(tetrahydrofuran-2-yl)-7-(trifluoromethyl)-1,4-dihydro-2H-quinazolin-3-yl)methanesulfonamide

Anesthetic Compounds

N-PHENYL-PRENYLAMINE DERIVATIVES FOR THE TREATMENT OF COGNITIVE, NEURODEGENERATIVE OR NEURONAL DISEASES OR DISORDERS

Benzoic Acid Derivatives that are Modulators or Agonists of GlyR

Compounds and their salts specific to the PPAR receptors and the EGF receptors and their use in the medical field

Anthranilic acid derivative or salt thereof

1,1′-(1,2-ethynediyl)bis-benzene derivatives as PTP 1-B inhibitors

Process for Preparing Quinazolinone Derivatives

Photocrosslinkable materials

Tetrafluorobenzyl derivatives and pharmaceutical composition for preventing and treating acute and chronic neurodegenerative diseases in central nervous system containing the same

Process of preparation of substituted tetrafluorobenzylaniline compound and its pharmaceutically approved salts

Substituted 1H-quinazoline-2,4-diones useful as AMPA receptor ligands

Substituted quinazolinones for treating neurological conditions

System and Device for Magnetic Drug Targeting with Magnetic Drug Carrier Particles

Tetrafluorobenzyl derivatives and pharmaceutical composition for preventing and treating acute and chronic neurodegenerative diseases in central nervous system containing the same

Tetrafluorobenzyl derivatives and pharmaceutical composition for preventing and treating acute and chronic neurodegenerative diseases in central nervous system containing the same

Phenyl compounds

KCNQ channel modulating compounds and their pharmaceutical use

Compounds, compositions and methods for preventing neurodegeneration in acute and chronic injuries in the central nervous system

Salts of 4- or 5-aminosalicylic acid

Pharmaceutical compounds

Tetrafluorobenzyl derivatives and pharmaceutical composition for preventing and treating acute and chronic neurodegenerative diseases in central nervous system containing the same

(2-((2-alkoxy)-phenyl) -cyclopent-1enyl) aromatic carbo and heterocyclic acid and derivatives

Synthesis of quinoline 5-carboxamides useful for the preparation of PDE IV inhibitors

Process for producing quinazolin-4-one derivative